2-amino-3-methylimidazo(4,5-f)quinoline has been researched along with 2,6-dihydroxyanthraquinone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayrton, AD; Ioannides, C; Lewis, DF; Walker, R | 1 |
1 review(s) available for 2-amino-3-methylimidazo(4,5-f)quinoline and 2,6-dihydroxyanthraquinone
| Article | Year |
|---|---|
Extrapolation of in vitro antimutagenicity to the in vivo situation: the case for anthraflavic acid.
Topics: Animals; Anthraquinones; Anticarcinogenic Agents; Antimutagenic Agents; Aroclors; Biotransformation; Carcinogens; Chlorodiphenyl (54% Chlorine); Microsomes, Liver; Mixed Function Oxygenases; Mutagenicity Tests; Quinolines; Rats; Salmonella typhimurium | 1993 |